AI-Driven Cancer Diagnosis and Prediction With EHR
ConditionTumor
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-90
SponsorThe Eye Hospital of Wenzhou Medical University
About this trial
This is a multi-center, clinical study designed to evaluate the application and effectiveness of an AI-assisted predictive model for identifying and diagnosing cancer, leveraging multimodal health data.
Eligibility criteria
Qualifiers
None
Disqualifiers
Patients with incomplete or missing key electronic health record data or insufficient follow-up data.
Individuals with severe cognitive disorders or other terminal illnesses that would prevent meaningful participation.
Pregnant women (although pediatric cancers are being considered, pregnant women would be excluded for safety reasons).
Trial design
Treatments tested in this trial
- AI-Based Diagnostic and Prognostic Model
Treatment groups
1,000,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
The Eye Hospital of Wenzhou Medical University
Lead sponsor
Wenzhou Medical University
Sponsor institution
Source ClinicalTrials.gov